# Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany - Inspection Records

Source: https://www.keypedia.com/companies/halo-pharmaceutical-inc-dba-cambrex-whippany/1464443d-ae5a-4d06-959c-d1ccb1b213a2

> Inspection records and compliance data for Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany in Whippany, New Jersey. Access full analysis and detailed observations.

---

## Details

- Name: Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany
- FEI Number: 2211084
- City: Whippany
- State: New Jersey
- Country Name: United States
- Address Line 1: 30 N Jefferson Rd
- Zip Code: 07981
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK

## Related Documents

- [FDA Inspection 1297650 - Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany - 2025-12-08](https://www.keypedia.com/records/fda_inspections/halo-pharmaceutical-inc-dba-cambrex-whippany/29257cf4-a977-4a40-b47c-8c6427a29fb0) — source: FDA, date: December 8, 2025
- [FDA Inspection 1297650 - Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany - 2025-12-08](https://www.keypedia.com/records/fda_inspections/halo-pharmaceutical-inc-dba-cambrex-whippany/ff5fde2e-4f0e-44b5-9fd6-ece34ceb3753) — source: FDA, date: December 8, 2025
- [FDA Inspection 1297650 - Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany - 2025-12-08](https://www.keypedia.com/records/fda_inspections/halo-pharmaceutical-inc-dba-cambrex-whippany/9af496ca-9605-43b9-b726-ec5a90c149a0) — classification: No Action Indicated (NAI), source: FDA, date: December 8, 2025
- [FDA Inspection 1297650 - Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany - 2025-12-08](https://www.keypedia.com/records/fda_inspections/halo-pharmaceutical-inc-dba-cambrex-whippany/f9f091ad-021c-420a-97b8-ef23a38ac54f) — classification: No Action Indicated (NAI), source: FDA, date: December 8, 2025
- [483 - Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany - 2023-02-17](https://www.keypedia.com/records/483/halo-pharmaceutical-inc-dba-cambrex-whippany/85c16a13-185e-4160-8506-5e5d9a880e64) — source: FDA, date: February 17, 2023
- [FDA Inspection 1197680 - Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany - 2023-02-17](https://www.keypedia.com/records/fda_inspections/halo-pharmaceutical-inc-dba-cambrex-whippany/977b66ca-6f39-4a4d-b230-c50aeda40300) — classification: No Action Indicated (NAI), source: FDA, date: February 17, 2023
- [EIR - Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany - 2019-12-20](https://www.keypedia.com/records/eir/halo-pharmaceutical-inc-dba-cambrex-whippany/811b1d79-833d-4528-bf63-382c0e77803e) — source: FDA, date: December 20, 2019
- [483 - Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany - 2019-12-20](https://www.keypedia.com/records/483/halo-pharmaceutical-inc-dba-cambrex-whippany/9b43103a-df0c-4d52-949f-0dabcb89d760) — source: FDA, date: December 20, 2019
- [FDA Inspection 1116333 - Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany - 2019-12-20](https://www.keypedia.com/records/fda_inspections/halo-pharmaceutical-inc-dba-cambrex-whippany/0063451d-1d8e-48f6-afb9-c2589f60c73b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 20, 2019
- [FDA Inspection 1055544 - Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany - 2018-05-30](https://www.keypedia.com/records/fda_inspections/halo-pharmaceutical-inc-dba-cambrex-whippany/00b592a9-1ab3-4d40-bb44-5de67256700c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 30, 2018
- [FDA Inspection 1027562 - Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany - 2017-08-24](https://www.keypedia.com/records/fda_inspections/halo-pharmaceutical-inc-dba-cambrex-whippany/1e78476d-5351-47de-8c53-bd1f0aae370e) — classification: No Action Indicated (NAI), source: FDA, date: August 24, 2017
- [483 - Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany - 2017-03-20](https://www.keypedia.com/records/483/halo-pharmaceutical-inc-dba-cambrex-whippany/a15123c4-43cf-4ac7-b91b-ae2b1bc3e1de) — source: FDA, date: March 20, 2017
- [EIR - Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany - 2017-03-20](https://www.keypedia.com/records/eir/halo-pharmaceutical-inc-dba-cambrex-whippany/bea5e98a-7d52-49f7-92d3-f6bee3c9ba28) — source: FDA, date: March 20, 2017
- [FDA Inspection 1008344 - Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany - 2017-03-20](https://www.keypedia.com/records/fda_inspections/halo-pharmaceutical-inc-dba-cambrex-whippany/9a730984-8411-4cbd-89ee-7407053ace5a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 20, 2017
- [FDA Inspection 974566 - Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany - 2016-05-27](https://www.keypedia.com/records/fda_inspections/halo-pharmaceutical-inc-dba-cambrex-whippany/2512a953-4d76-4795-8e6d-b4ce4de9793d) — classification: No Action Indicated (NAI), source: FDA, date: May 27, 2016

## Related Companies

- [Vericel Corporation](https://www.keypedia.com/companies/vericel-corporation/1955c523-5115-491b-a705-2c526deb9ff6)
- [Norbrook Laboratories Limited](https://www.keypedia.com/companies/norbrook-laboratories-limited/c9294f28-e127-43a0-b824-82a6f41fabfd)
- [Advanced Accelerator Applications (Italy) srl](https://www.keypedia.com/companies/advanced-accelerator-applications-italy-srl/09ac059c-6735-4082-8674-a88476dbdbc6)
- [Aprecia Pharmaceuticals LLC](https://www.keypedia.com/companies/aprecia-pharmaceuticals-llc/126049a3-6c3d-4616-8d44-006827a308c3)
- [AgroChem USA, LLC](https://www.keypedia.com/companies/agrochem-usa-llc/007b3455-bf3c-4d23-b1e7-0be79ebba21e)
- [OMRIX Biopharmaceuticals LTD](https://www.keypedia.com/companies/omrix-biopharmaceuticals-ltd/bf1b8f1e-b1c7-47be-bb38-f85e1cff944d)
- [Shionogi Pharma Co., Ltd.](https://www.keypedia.com/companies/shionogi-pharma-co-ltd/bb3e5dcd-52f9-4971-9747-4c04b63ba0fa)
- [Bristol-Myers Squibb Company](https://www.keypedia.com/companies/bristol-myers-squibb-company/b20ef646-d409-4268-af48-ddf4c16f82cc)
- [Amgen, Inc.](https://www.keypedia.com/companies/amgen-inc/85ec512e-6991-42ee-9cd5-148cfe0ed3e8)
- [Pharmacia & Upjohn Company LLC](https://www.keypedia.com/companies/pharmacia-upjohn-company-llc/de0a9227-069b-44f4-a9b3-21db78c27480)

## Related Officers

- [Jogy George](https://www.keypedia.com/people/jogy-george/00ef0915-66d2-4b34-9b74-d1e08caf2db3)
- [Director of Clinical Training](https://www.keypedia.com/people/helen-verdel/f6caf5a8-74f5-4833-bd00-5579b369f4f9)
- [company_representative](https://www.keypedia.com/people/susan-saffar/30088266-5231-4727-b079-4ce60b7aaddf)
- [investigator](https://www.keypedia.com/people/zhijin-chen/83b97abc-e295-4085-ac58-a4e7349620be)
- [Consumer Safety Officer/ORA/OMPTO/TOS](https://www.keypedia.com/people/niketa-patel/73efe456-da61-4345-8dec-7147b12b88d1)